Washington's Department of Health has proposed stricter standards for cannabis products that carry the state's official medical-grade designation.
The proposal, published in the Washington State Register on Oct. 15, would sharply lower the allowed levels of heavy metals. Arsenic would drop from 2.0 to 0.20 micrograms per gram, cadmium from 0.82 to 0.20, lead from 1.2 to 0.50 and mercury from 0.40 to 0.10.
It would also make terpene testing mandatory for qualifying medical-grade products. Labs would measure nine specific terpenes, including limonene, myrcene, linalool and caryophyllene. Flower and concentrate labels would list the three most prominent terpenes, and flower labels would add a harvest date. The rules would also change what counts as a high-CBD product and introduce redesigned medical-grade logos.
The state estimates terpene testing would cost producers about $25 to $35 per batch and says some costs could be passed on to patients.
These standards apply only to products seeking the medical-grade label, not to every product on the shelf. A virtual public hearing is set for Nov. 10, with Nov. 17 named as the intended adoption date. Nothing is final yet.
What it means for travelers: Today's Washington shopping trip doesn't change. If the rules pass, terpene info on medical-grade labels would make it easier to compare flavor and aroma profiles. That's a handy habit for reading any cannabis label.






